Document |
Document Title |
WO/2022/163871A1 |
A wastewater treatment apparatus and method for wastewater containing an organic chromaticity component, the treatment being with an enzyme produced by Bacillus proteolyticus.
|
WO/2022/155881A1 |
Provided is a skin source bacteria KBFS1720 having a skin ultraviolet burn repair function, and an application thereof. Also provided is a method for culturing the skin source bacteria.
|
WO/2022/157507A1 |
There is described a process for producing at least one of mycoprotein and the components thereof, the process comprising: (i) providing a fermentation media suitable for producing mycoprotein; (ii) fermenting the fermentation media to o...
|
WO/2022/157326A1 |
The present disclosure relates to a food product comprising fungi biomass and at least one food additive, the fungi biomass comprising a filamentous mycelium network wherein the at least one food additive is present in an amount of 0.05%...
|
WO/2022/156027A1 |
A cell strain for the malignant transformation of human keratinocytes caused by thiodimethylarsenic acid and the use thereof, which belong to the technical field of model construction. By means of the present invention, continuous exposu...
|
WO/2022/156055A1 |
Provided is the microcin MccY, wherein the amino acid sequence of the microcin is GGRGHIAEYFSGPITQVAFYG. Further provided are a method for preparing the microcin and the use thereof. Compared with MccJ25 which only has bactericidal activ...
|
WO/2022/157556A1 |
Disclosed are Epichloë endophytes that produce bioactive secondary metabolites in symbiotic association with a host plant, particularly a grass host plant. Also disclosed are methods of using these endophytes to confer pest resistance o...
|
WO/2022/156402A1 |
Provided are a 1,3/1,4-xylanase MLX1034, a gene encoding same, and an application thereof. The xylanase MLX1034 is isolated from Polaribacter sp. Q13, and has the amino acid sequence as shown in SEQ ID NO. 1, and the nucleotide sequence ...
|
WO/2022/158814A1 |
The present invention relates to microalgae of Chlorella genus HS-LZ (Chlorella sp. HS-LZ), which are novel microalgae having the characteristic of being capable of producing zeaxanthin and lutein, and uses thereof.
|
WO/2022/151611A1 |
Provided are a cytochrome P450 enzyme mutant and an application thereof. The enzyme activity and anti-Markov oxidation selectivity of P450 derived from a wild-type strain of Bacillus megaterium undergo protein modification by means of di...
|
WO/2022/151790A1 |
A Bifidobacterium longum dietary combination for intervening with chronic nephritis and uremia, and the use thereof. The Bifidobacterium longum dietary combination comprises 100 mL of Bifidobacterium longum BL-G301 probiotic milk and 40 ...
|
WO/2022/151700A1 |
Provided is a method for promoting growth of E. coli and increasing the yield of a fermented product, which is characterized by knocking out a pilus gene cluster on an E. coli genome, the pilus gene cluster being: yagV-Z, gltF-yhcF, fimA...
|
WO/2022/151078A1 |
Provided are an oncolytic virus and an application thereof. The oncolytic virus contains a recombinant nucleic acid. The recombinant nucleic acid comprises: (i) a first nucleic acid fragment for encoding a soluble PD-1 molecule; (ii) a s...
|
WO/2022/151669A1 |
Provided is an isolated strain of Lactobacillus amylovorus LAM1345, which is deposited at Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH under an accession number DSM 33510. Also provided are a composition including the isol...
|
WO/2022/152036A1 |
Provided are a polynucleotide having promoter activity and use thereof in the production of target compounds. Specifically, provided are a polynucleotide having promoter activity, a transcriptional expression cassette, recombinant expres...
|
WO/2022/152914A1 |
The present invention is in the technical field of synthetic biology and metabolic engineering. More particularly, the present invention is in the technical field of cultivation of metabolically engineered cells. The present invention de...
|
WO/2022/152615A1 |
The present invention relates to a novel Streptococcus thermophilus strain having improved texturizing properties, compositions comprising said strain as well as fermented products manufactured using said strain.
|
WO/2022/148362A1 |
Provided is an engineering probiotic having surface display phenylalanine ammonia-lyase. The engineering probiotic knocks out a gene argR and/or undergoes a gene argA(Y19C) mutation on an Escherichia coli Nissle 1917 genome, and integrat...
|
WO/2022/147873A1 |
Provided are a method for preparing an avocado oil-in-water liquid fermented product and the use thereof in cosmetics. The fermented product effectively converts proteins, nucleic acids, polysaccharides, etc. into a small-molecule water-...
|
WO/2022/150596A1 |
The present invention relates to processes for preparing linkers that are useful in the conjugation of therapeutic molecules (e.g., cytotoxic agents) with targeting moieties (e.g., proteins, peptides, antibodies, nanoparticles, nucleic a...
|
WO/2022/150258A1 |
A method of aerobic microbial processing comprising: culturing microbes comprising a (per)chlorate respiration pathway in a bioreactor in a bioprocess employing microbial respiration of chloroxyanions as a source of oxygen for the biopro...
|
WO/2022/147680A1 |
Disclosed in the present invention is a preparation method for meso-2,3-butanediol, comprising the following steps: using renewable biomass as raw material, and producing 2,3-butanediol by means of the fermentation of Klebsiella to obtai...
|
WO/2022/149296A1 |
[Problem] To provide a breakthrough method for producing a silk fermentation product using a lactic acid bacterium, whereby it becomes possible to produce a health food material or a cosmetic material that can enhance various functions o...
|
WO/2022/148138A1 |
Lactobacillus crispatus Lc31 and Lc83 capable of preventing and/or treating cervical squamous carcinoma. The preservation number of the Lactobacillus crispatus Lc31 is CGMCC No. 21348, and the preservation number of the Lactobacillus cri...
|
WO/2022/148008A1 |
Provided are a bacillus subtilis genetically engineered bacterium for producing tagatose and a method for preparing tagatose. The genetically engineered bacterium comprises constructing thermostable α-glucan phosphorylases, thermostable...
|
WO/2022/148314A1 |
The present invention relates to the use of an exogenous ATG10S protein in the preparation of an antiviral drug. The exogenous ATG10S is an rhATG10S protein, the coding nucleotide sequence thereof is as shown in SEQ ID NO: 1 or SEQ ID NO...
|
WO/2022/148191A1 |
Provided is Wickerhamomyces ciferrii, which has a deposit number of CGMCC No: 19562. Further provided is a method for screening Wickerhamomyces ciferrii, and the use thereof in the production of tetraacetyl phytosphingosine (TAPS).
|
WO/2022/149697A1 |
The present invention relates to a composition for controlling anti-obesity activity, containing, as an active ingredient, a Moringa oleifera fermentation product prepared using a novel Monascus purpureus SL1 strain. The Moringa oleifera...
|
WO/2022/148351A1 |
The present invention relates to the field of bioengineering and medical chemical production. In particular, provided is a polynucleotide comprising a coding sequence of toluene dioxygenase. Also provided are an expression cassette, a ve...
|
WO/2022/146096A1 |
The present invention relates to a novel microorganism, a lysate thereof, a culture medium, an extract of the culture medium, vesicles, and anti-inflammatory and/or antibacterial uses thereof. A novel strain and vesicles derived therefro...
|
WO/2022/143646A1 |
Provided are a recombinant strain for producing L-glutamic acid by modifying a gene BBD29_09525, and a construction method therefor and an application thereof. The recombinant strain is a bacterium that generates L-glutamic acid and has ...
|
WO/2022/146235A1 |
The present invention relates to a method for producing an enantiomerically pure or enantiomerically enriched (R)- mandelic acid or a derivative thereof using one or more recombinant microbial cells genetically engineered to overexpress ...
|
WO/2022/142969A1 |
A method for preparing xylitol by fermenting xylose secondary mother liquor, comprising the steps of performing fermentation treatment on mixed liquor of xylose secondary mother liquor and xylose concentrated liquor, and replacing subseq...
|
WO/2022/144796A1 |
A method executed by an engine of a computing device for simulating microalgae fermentation is described. The engine receives an input from a user. The input includes an identification of a microalgae, an identification of a culture medi...
|
WO/2022/145807A1 |
The present application relates to a Bifidobacterium animalis subsp. lactis HEM20-01 strain (KCTC14143BP), and a composition comprising the strain for treating, preventing, or alleviating depression. Bifidobacterium animalis subsp. lacti...
|
WO/2022/146137A1 |
The present invention relates to a compound, represented by formula (I): (I) wherein a) R, R1, R2 and R4 are independently of one another a hydrogen 0 atom or a C1-C6 linear or branched alkyl, or a C1-C6 linear or branched alkenyl, or a ...
|
WO/2022/143763A1 |
Disclosed are a strain having enhanced L-glutamic acid productivity, a construction method therefor, and an application thereof. Point mutation is introduced into a wild type BBD29-00405 gene in corynebacterium glutamicum, so that the 59...
|
WO/2022/143550A1 |
The present invention provides a mesothelin binding molecule, comprising an anti-mesothelin single domain antibody. Complementarity determining regions (CDR) of the single domain antibody comprise CDR1 shown in SEQ ID NO: 1, CDR2 shown i...
|
WO/2022/143596A1 |
Provided is a method for displaying a polypeptide of interest such as full-length IgG antibody on yeast host cells, wherein heavy chain and light chain of polypeptide are expressed in two cassettes. ER-targeting peptide and the secretion...
|
WO/2022/141934A1 |
Disclosed in the present invention are Staphylococcus aureus standard strains, which respectively have deposit numbers of GDMCC 60841, GDMCC 60843, GDMCC 60844 and GDMCC 60845, and can be used in different fields such as food, medicine a...
|
WO/2022/141944A1 |
The present invention provides three strains of Campylobacter jejuni, the preservation number of the strain 346-1C being GDMCC 60857, the preservation number of the strain 3853-1A being GDMCC 60858, and the preservation number of the str...
|
WO/2022/145901A1 |
The present invention relates to a composition for preventing or treating cancer comprising, as an active ingredient, nanovesicles derived from a Lactobacillus fermentum strain isolated from kimchi. The Lactobacillus fermentum strain-der...
|
WO/2022/145902A1 |
The present invention relates to a composition for the prevention or treatment of cancer, comprising, as an active ingredient, nanovesicles derived from a Lactobacillus sakei strain isolated from Kimchi. The nanovesicles derived from a L...
|
WO/2022/146718A1 |
Genetically engineered bacteria, pharmaceutical compositions thereof, and methods of modulating and treating diseases associated with hyperphenylalaninemia are disclosed.
|
WO/2022/147251A1 |
Disclosed herein are methods and compositions useful for the treatment of Autism Spectrum Disorder (ASD). The methods and compositions include combination therapy with probiotics and oxytocin (OXT), resulting in a therapeutic synergy tha...
|
WO/2022/143581A1 |
The present invention relates to the field of renewable energy sources in biotechnology, in particular to a method for producing citric acid by means of degrading coarse feed using a naturally symbiotic mixed culture. The mixed culture Y...
|
WO/2022/145600A1 |
The present invention relates to: Debaryomyces hansenii SMFM201812-3 strain having meat tenderizing and flavor-improving functions; Debaryomyces hansenii SMFM201905-5 strain; a meat tenderizing and flavor-improving composition and a meat...
|
WO/2022/141939A1 |
The present invention relates to the technical field of bioengineering, and in particular relates to three Vibrio parahaemolyticus standard strains which conform to domestic propagation laws and can be used as standard reference strains ...
|
WO/2022/144783A1 |
A method executed by a bioreactor system to cultivate a microalgae comprising a photoreceptor sensitive to a region of a visible spectrum under an autotrophic condition and a fermentation condition is described. A first process incubates...
|
WO/2022/143225A1 |
Provided are an engineered bacteria for producing pseudouridine and an application thereof. The engineered bacteria is obtained by means of gene-cloning pseudouridine synthetic genes pumH, pumJ and pumD from Streptomyces sp.ID38640 into ...
|